Stocks News

LAST PRICE
220.5600
TODAY'S CHANGE (%)
Trending Up8.0300 (3.7783%)

Bid / Lots
219.4100/ 5
Ask / Lots
220.5600/ 10
Open / Previous Close
218.8900 / 212.5300
Day Range
Low 217.7100
High 221.0000
52 Week Range
Low 126.9681
High 221.0000
Volume
64,748
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- BeiGene Shares Climb Pre-Bell After FDA Gives Favorable Opinion on Class of Cancer Treatments, from 3 hours ago by MT Newswires
  3 hours ago by MT Newswires
  Companies Mentioned: BGNE
  06:40 AM EDT, 09/27/2024 (MT Newswires) -- BeiGene (BGNE) shares were up 3.5% in Friday's premarket activity after it said that the US Food and Drug Administration's Oncologic Drugs Advisory Committee had recognized the "favorable benefit-risk profi...
Yesterday
- BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA(R), for Treatment of ESCC and Gastric/GEJ Cancers, from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
  Companies Mentioned: BGNE
  
  Slow the rate of infusion for mild (Grade 1) and interrupt the infusion for moderate (Grade 2) infusion-related reactions. For severe (Grade 3) or life-threatening (Grade 4) infusion-related reactions, stop infusion and permanently discontinue TEVIMBRA.
- Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors, from 6:00AM ET on Thursday Sep 26, 2024 by Dow Jones
  6:00AM ET on Thursday Sep 26, 2024 by Dow Jones
  Companies Mentioned: BGNE
  
  BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Shalini Sharp to its Board of Directors and as a member of the Board's Audit Committee, effective September 27, 2024.
- *DJ BeiGene Appoints Shalini Sharp to Board of Directors, from 6:00AM ET on Thursday Sep 26, 2024 by Dow Jones
  6:00AM ET on Thursday Sep 26, 2024 by Dow Jones
  Companies Mentioned: BGNE
Sep 18, 2024
- JMP Securities Initiates BeiGene at Outperform With $288 Price Target, from 7:14AM ET on Wednesday Sep 18, 2024 by MT Newswires
  7:14AM ET on Wednesday Sep 18, 2024 by MT Newswires
  Companies Mentioned: BGNE
  07:14 AM EDT, 09/18/2024 (MT Newswires) -- BeiGene (BGNE) has an average buy rating and a price target range of $152 to $345, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks a...

Today
- DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 4 minutes ago by Dow Jones
  4 minutes ago by Dow Jones
  Companies Mentioned: NBIX, ABBV, BMY
- DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: NBIX, ABBV, BMY
Sep 24, 2024
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting, from 7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
  7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
  Companies Mentioned: UTHR
Sep 23, 2024
- DJ United Therapeutics Is Maintained at Buy by Jefferies, from 11:30AM ET on Monday Sep 23, 2024 by Dow Jones
  11:30AM ET on Monday Sep 23, 2024 by Dow Jones
  Companies Mentioned: UTHR
- DJ S&P 500 Futures Up In Premarket Trading; Simpson Manufacturing, Intel Lead, from 7:30AM ET on Monday Sep 23, 2024 by Dow Jones
  7:30AM ET on Monday Sep 23, 2024 by Dow Jones
  Companies Mentioned: EXAS, INTC, MTH, RDN, SSD, GM, CIEN
Sep 19, 2024
- Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by PR Newswire
  4:01PM ET on Thursday Sep 19, 2024 by PR Newswire
  Companies Mentioned: NBIX
- Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
  4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
  Companies Mentioned: NBIX
Sep 18, 2024
- BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO(R) (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting, from 8:01AM ET on Wednesday Sep 18, 2024 by PR Newswire
  8:01AM ET on Wednesday Sep 18, 2024 by PR Newswire
  Companies Mentioned: BMRN
- BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO(R) (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting, from 8:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
  8:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
  Companies Mentioned: BMRN
Sep 17, 2024
- DJ BioMarin Pharmaceutical Is Maintained at Sector Perform by Scotiabank, from 11:35AM ET on Tuesday Sep 17, 2024 by Dow Jones
  11:35AM ET on Tuesday Sep 17, 2024 by Dow Jones
  Companies Mentioned: BMRN

Beigene Ltd
NASDAQ:BGNEUnited States

Search Criteria

Today

BeiGene Shares Climb Pre-Bell After FDA Gives Favorable Opinion on Class of Cancer Treatments, from 3 hours ago by MT Newswires

Yesterday

BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA(R), for Treatment of ESCC and Gastric/GEJ Cancers, from 15 hours ago by Dow Jones

Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors, from 6:00AM ET on Thursday Sep 26, 2024 by Dow Jones

*DJ BeiGene Appoints Shalini Sharp to Board of Directors, from 6:00AM ET on Thursday Sep 26, 2024 by Dow Jones

Sep 18, 2024

JMP Securities Initiates BeiGene at Outperform With $288 Price Target, from 7:14AM ET on Wednesday Sep 18, 2024 by MT Newswires

Peers Headlines

Today

DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 4 minutes ago by Dow Jones

DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 1 hour ago by Dow Jones

Sep 24, 2024

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting, from 7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones

Sep 23, 2024

DJ United Therapeutics Is Maintained at Buy by Jefferies, from 11:30AM ET on Monday Sep 23, 2024 by Dow Jones

DJ S&P 500 Futures Up In Premarket Trading; Simpson Manufacturing, Intel Lead, from 7:30AM ET on Monday Sep 23, 2024 by Dow Jones

Sep 19, 2024

Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by PR Newswire

Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones

Sep 18, 2024

Sep 17, 2024

DJ BioMarin Pharmaceutical Is Maintained at Sector Perform by Scotiabank, from 11:35AM ET on Tuesday Sep 17, 2024 by Dow Jones